![](https://investorshub.advfn.com/uicon/607320.png?cb=1602587228)
Wednesday, October 14, 2020 3:55:46 PM
Senior Clinical Trial Manager at Innovation Pharmaceuticals Inc
Experience
Innovation Pharmaceuticals Inc
Senior Clinical Trial Manager
Innovation Pharmaceuticals Inc
Sep 2020 - Present2 months
United States
Sanofi
Senior Manager, Clinical Trial Operations, Oncology, at Sanofi US
Sanofi
Jun 2016 - Sep 20204 years 4 months
Bridgewater, NJ
Novartis
Senior Clinical Study Manager/Clinical Trial Head for Novartis (Home Based)
Novartis
Aug 2015 - Mar 20168 months
Greater New York City Area
ICON plc
Clinical Project Manager, Medical Imaging
ICON plc
Nov 2014 - Jun 20158 months
Warrington, Pennsylvania
Bristol-Myers Squibb
Clinical Protocol Manager / Clinical Scientist
Bristol-Myers Squibb
Aug 2013 - Nov 20141 year 4 months
Plainsboro, NJ
BioClinica
Oncology Project Manager
BioClinica
Jul 2012 - Feb 20138 months
Newtown, PA
Purdue Pharma L.P.
Program Manager
Purdue Pharma L.P.
2011 - Sep 20121 year
Cranbury, NJ
MDS Pharma Services
Global Project Manager III
MDS Pharma Services
2007 - 20103 years
North Brunswick, NJ
RadPharm Inc.
Project Leader
RadPharm Inc.
2004 - 20073 years
Princeton, NJ
Education
Rutgers, The State University of New Jersey-New BrunswickRutgers, The State University of New Jersey-New Brunswick
Rutgers, The State University of New Jersey-New Brunswick
BALate Victorian & Edwardian Literature, European HistoryCum Laude
1998 - 2004
Late Victorian & Edwardian Literature
Shakespeare
Chaucer
Dickens, Hardy, Poe
https://www.linkedin.com/in/erica-silverstein-lakatos-94596a39/
Bring on the trial! I know there are a bunch of us that are ready...
Go Leo & IPIX!
Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials (a total of 8) for other clinical indications, providing an established safety and efficacy database on over 460 subjects, thereby potentially enabling it to
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM